376 related articles for article (PubMed ID: 29943219)
1. Ablation energies for focal treatment of prostate cancer.
Lodeizen O; de Bruin M; Eggener S; Crouzet S; Ghai S; Varkarakis I; Katz A; Dominguez-Escrig JL; Pahernik S; de Reijke T; de la Rosette J
World J Urol; 2019 Mar; 37(3):409-418. PubMed ID: 29943219
[TBL] [Abstract][Full Text] [Related]
2. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
[TBL] [Abstract][Full Text] [Related]
3. Target ablation--image-guided therapy in prostate cancer.
Marien A; Gill I; Ukimura O; Betrouni N; Villers A
Urol Oncol; 2014 Aug; 32(6):912-23. PubMed ID: 24411788
[TBL] [Abstract][Full Text] [Related]
4. Focal therapy of prostate cancer: energies and procedures.
Bozzini G; Colin P; Nevoux P; Villers A; Mordon S; Betrouni N
Urol Oncol; 2013 Feb; 31(2):155-67. PubMed ID: 22795500
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Magn Reson Imaging Clin N Am; 2015 Nov; 23(4):607-19. PubMed ID: 26499278
[TBL] [Abstract][Full Text] [Related]
6. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
7. Surveillance after prostate focal therapy.
Tay KJ; Amin MB; Ghai S; Jimenez RE; Kench JG; Klotz L; Montironi R; Muto S; Rastinehad AR; Turkbey B; Villers A; Polascik TJ
World J Urol; 2019 Mar; 37(3):397-407. PubMed ID: 29948045
[TBL] [Abstract][Full Text] [Related]
8. Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature.
Hayes M; Lin-Brande M; Isharwal S
Oncology (Williston Park); 2021 May; 35(5):261-268. PubMed ID: 33983695
[TBL] [Abstract][Full Text] [Related]
9. Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
Borges RC; Tourinho-Barbosa RR; Glina S; Macek P; Mombet A; Sanchez-Salas R; Cathelineau X
J Urol; 2021 Jan; 205(1):129-136. PubMed ID: 33119421
[TBL] [Abstract][Full Text] [Related]
10. Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement.
Ganzer R; Arthanareeswaran VKA; Ahmed HU; Cestari A; Rischmann P; Salomon G; Teber D; Liatsikos E; Stolzenburg JU; Barret E
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):175-186. PubMed ID: 29743538
[TBL] [Abstract][Full Text] [Related]
11. Contemporary treatments in prostate cancer focal therapy.
Ahdoot M; Lebastchi AH; Turkbey B; Wood B; Pinto PA
Curr Opin Oncol; 2019 May; 31(3):200-206. PubMed ID: 30865133
[TBL] [Abstract][Full Text] [Related]
12. An update on focal therapy for prostate cancer.
Perera M; Krishnananthan N; Lindner U; Lawrentschuk N
Nat Rev Urol; 2016 Nov; 13(11):641-653. PubMed ID: 27670618
[TBL] [Abstract][Full Text] [Related]
13. Image-guided focal therapy for prostate cancer.
Sankineni S; Wood BJ; Rais-Bahrami S; Walton Diaz A; Hoang AN; Pinto PA; Choyke PL; Türkbey B
Diagn Interv Radiol; 2014 Nov; 20(6):492-7. PubMed ID: 25205025
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive treatment for localized prostate cancer.
Porres D; Pfister D; Heidenreich A
Minerva Urol Nefrol; 2012 Dec; 64(4):245-53. PubMed ID: 23288211
[TBL] [Abstract][Full Text] [Related]
15. MRI-guided interventions for the treatment of prostate cancer.
Bomers JG; Sedelaar JP; Barentsz JO; Fütterer JJ
AJR Am J Roentgenol; 2012 Oct; 199(4):714-20. PubMed ID: 22997360
[TBL] [Abstract][Full Text] [Related]
16. Focal therapy in the management of localized prostate cancer.
Nguyen CT; Jones JS
BJU Int; 2011 May; 107(9):1362-8. PubMed ID: 21223478
[TBL] [Abstract][Full Text] [Related]
17. Locally ablative therapies for primary and metastatic liver cancer.
Li D; Kang J; Madoff DC
Expert Rev Anticancer Ther; 2014 Aug; 14(8):931-45. PubMed ID: 24746315
[TBL] [Abstract][Full Text] [Related]
18. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
19. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI.
Connor MJ; Gorin MA; Ahmed HU; Nigam R
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):232-243. PubMed ID: 32051551
[TBL] [Abstract][Full Text] [Related]
20. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
